Haemonetics Corp

NYSE:HAE

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is HAE's stock price target?

Price Target

107.68 USD

According to Wall Street analysts, the average 1-year price target for HAE is 107.68 USD with a low forecast of 88.88 USD and a high forecast of 126 USD.

What is Haemonetics Corp's Revenue forecast?

Projected CAGR

9%

For the last 8 years the compound annual growth rate for Haemonetics Corp's revenue is 3%. The projected CAGR for the next 4 years is 9%.

What is Haemonetics Corp's Operating Income forecast?

Projected CAGR

27%

For the last 8 years the compound annual growth rate for Haemonetics Corp's operating income is 6%. The projected CAGR for the next 4 years is 27%.

What is Haemonetics Corp's Net Income forecast?

Projected CAGR

29%

For the last 8 years the compound annual growth rate for Haemonetics Corp's net income is 27%. The projected CAGR for the next 4 years is 29%.